Trending...
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
- Lt. Governor Primavera Tours U.S. Olympic & Paralympic Museum in Colorado Springs, Highlights Investments to Increase Museum Accessibility
- $38 Million in U.S. Government Contract Awards Secured Through Strategic Partner. Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
Emerging biotech firm debuts "Science & Shield" initiative, bridging the gap between advanced medical research and immediate humanitarian relief for the Ozarks.
BRANSON, Mo. - ColoradoDesk -- Metavalis, a biotechnology innovator developing a proprietary Stealth Lipid Nanoparticle (LNP) platform, is proud to announce the launch of its "Science & Shield" humanitarian initiative. To mark this milestone, the company has partnered with community organizers to host a massive winter aid event in Branson.
While Metavalis is pioneering a new generation of stealth delivery systems to tackle rare and challenging diseases, the company's leadership maintains that advanced science must be paired with immediate community care.
"Our stealth LNP technology is designed to go where other treatments can't, solving the hardest problems in medicine," said Jordan Bekemeier, Founder and CEO of Metavalis. "But while we engineer solutions for the future, we also have to solve the problems right in front of us. That is why we are deploying resources today not just in the lab, but in the parking lot, handing out supplies to neighbors who are struggling."
More on Colorado Desk
Event Details:
A Dual Layer of Support The event is a coordinated effort to provide comprehensive winter protection:
About Metavalis Metavalis is a biotechnology company focused on the treatment of rare and challenging diseases through its novel Stealth LNP platform. By engineering delivery vehicles that evade immune detection, Metavalis aims to unlock new possibilities in genetic medicine. The "Science & Shield" program represents the company's commitment to protecting human life at every level from the cellular to the community.
For more information, visit the Metavalis website.
While Metavalis is pioneering a new generation of stealth delivery systems to tackle rare and challenging diseases, the company's leadership maintains that advanced science must be paired with immediate community care.
"Our stealth LNP technology is designed to go where other treatments can't, solving the hardest problems in medicine," said Jordan Bekemeier, Founder and CEO of Metavalis. "But while we engineer solutions for the future, we also have to solve the problems right in front of us. That is why we are deploying resources today not just in the lab, but in the parking lot, handing out supplies to neighbors who are struggling."
More on Colorado Desk
- Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
- At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
- Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
- VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
- Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
Event Details:
- Date: Saturday, February 7, 2026
- Time: 12:00 PM – 3:00 PM CST
- Location: 993 Branson Hills Parkway, Branson, MO (Parking lot)
A Dual Layer of Support The event is a coordinated effort to provide comprehensive winter protection:
- The Davis Family will be distributing a massive supply of winter coats, hats, and heavy weather gear to protect against the cold.
- Metavalis will be distributing "Shield Kits" care packages containing non perishable food, first aid supplies (band aids, sanitizers), and hygiene essentials.
About Metavalis Metavalis is a biotechnology company focused on the treatment of rare and challenging diseases through its novel Stealth LNP platform. By engineering delivery vehicles that evade immune detection, Metavalis aims to unlock new possibilities in genetic medicine. The "Science & Shield" program represents the company's commitment to protecting human life at every level from the cellular to the community.
For more information, visit the Metavalis website.
Source: Metavalis Inc.
Filed Under: Health
0 Comments
Latest on Colorado Desk
- Colorado: Governor Polis Announces Lieutenant Governor Primavera as Interim Behavioral Health Commissioner
- Governor Polis Signs Bill Into Law Boosting Innovation in Agriculture and Protecting Colorado Forests from Mountain Pine Beetles
- Colorado Springs: Spring Creek Aquatic Ecosystem Restoration: Integrated Feasibility Report & Environment Assessment
- Colorado: Governor Polis Visits Community College of Aurora to Celebrate the New Center for Applied Science and Technology Building
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- Colorado: CPW Offers $1 Million in Grants to Reduce Human-Bear Conflicts in Local Communities
- Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
- Primeindexer Google indexing platform launched by SEO Danmark APS
- Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
- We are all living in a simulation, and this game just proved it
- Talentica Announces Winners of Multi-Agent Hackathon 2026
- Colorado: Governor Polis Memorializes Verbal Disaster Declaration for Highly Pathogenic Avian Influenza in Weld County
- Colorado: Department of Local Affairs Announces Inaugural Transit Oriented Communities Infrastructure Grant Awards
- Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
- Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
- Cancun All Inclusive is ready for Spring Break 2026 with new Resorts, Exclusive Deals, activities and more!
- 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
- Ludex Partners With Certified Trading Card Association (CTCA) To Elevate Standards And Innovation In The Trading Card Industry



